Symposium Program
ISLH 2025 Educational Content
Educational Program
The ISLH Annual Meeting is a 3 day conference preceded by a one-day educational workshop.
Friday, May 9th
8:00 - 8:30 AM
|
BREAK: COFFEE BREAK / EXHIBITS
Ballroom |
||||
8:00 - 8:15 AM
|
MEETING: BUSINESS MEETING
Hall C1 |
||||
8:30 - 10:00 AM
|
CONCURRENT SESSION: CONCURRENT 10: UPDATES ON QUALITY IN HEMATOLOGY LABS Chair/Organizer: Swati Pai, Sumedha Kulkarni
Hall C1 |
||||
8:30 |
What is the Point of Automated Haematology Counting EQA? Barbara De La Salle. UK NEQAS Haematology |
|||||
9:00 |
Process of Developing a Reference Method and Primary Standard for PT/INR Measurement Ton van den Besselaar. Leiden University Medical Center |
|||||
9:30 |
Using CLSI Documentary Standards to Bring Quality to the Clinical Flow Cytometry Laboratory Virginia Litwin. Eurofins/ISAC |
|||||
| |
CONCURRENT SESSION: CONCURRENT 9: UPDATES ON ACQUIRED RED BLOOD CELL DISORDERS Chair/Organizer: Marian Rollins-Raval, Sarah Patterson
Hall C4 |
||||
8:30 |
VEXAS-Morphologic Findings in 52 Patients (AJCP paper) & Vacuolization of Erythroid Precursors: Etiologies and Management Saja Asakrah. Emory School of Medicine, Department of Pathology and Laboratory Medicine |
|||||
9:00 |
Anemia of Inflammation - Pathophysiology and Diagnosis Menaka Pai. McMaster University |
|||||
9:30 |
Structural Sexism in Medicine (Iron Deficiency Anemia) Michelle Sholzberg. St. Michael's Hospital |
|||||
10:00 - 10:45 AM
|
BREAK: COFFEE BREAK / EXHIBITS
Ballroom |
||||
10:45 - 11:45 AM
|
PLENARY SESSION: SPECIAL PLENARY: ARTIFICIAL INTELLIGENCE Chair/Organizer: Giuseppe d'Onofrio, Martha Eva Viveros
Hall C1 |
||||
10:45 |
Artificial Intelligence in Clinical Flow Cytometry: Utilization and Validation for Clinical Purpose (Implementation) Wolfgang Kern. MLL Munich Leukemia Laboratory |
|||||
11:15 |
Artificial Intelligence Application in Flow Cytometry for Use of Detection of Minimal Residual Disease in Chronic Lymphatic Leukemia Min Shi. Mayo Clinic |
|||||
12:15 - 1:15 PM
|
CORPORATE WORKSHOP: CORPORATE LUNCH WORKSHOP - SIEMENS HEALTHINEERS
Hall C4 Laboratory Implications for Hemophilia Gene Therapy and Other Novel Hemophilia Treatments After several decades of basic science and pre-clinical investigation hemophilia gene therapy has entered the clinic. Several Phase 3 studies have now been completed, and three hemophil. (show more) |
||||
1:45 - 3:15 PM
|
CONCURRENT SESSION: CONCURRENT 11: CELLULAR ANALYSIS: DIGITAL HEMATOPATHOLOGY / PATHOLOGY / NEW CONCEPTS Chair/Organizer: Gina Zini, Tracy George
Hall C1 |
||||
1:45 |
Digitalization in Hematopathology: What Has Changed? Olga Pozdnyakova. |
|||||
2:15 |
Diagnostic Hematopathology Approach to Eosinophilia George Deeb. Emory University |
|||||
2:45 |
Current Challenges and Opportunities in Digital Hematopathology Clinton Campbell. McMaster University |
|||||
| |
CONCURRENT SESSION: CONCURRENT 12: BLEEDING DISORDERS: DIAGNOSIS AND TREATMENT Chair/Organizer: Karen Moffat, Martha Eva Viveros
Hall C4 |
||||
1:45 |
Update on Laboratory Diagnosis of Von Willebrand Disease Kristi Smock. |
|||||
2:15 |
Challenges of Diagnosing Hereditary Bleeding Disorders in Resource-Challenged Countries Anthony Chan. McMaster University |
|||||
2:45 |
Fibrinogen Deficiencies Natalie Mathews. Centre Hospitalier Universitaire Sainte-Justine |
|||||